Recently, the favorable effect of erythropoietin (EPO) on mitochondrial functionality was examined in both in vivo and in vitro models of Parkinson’s disease, in which augmented oxidative stress leads to mitochondrial disfunction, neuronal apoptosis, and cell toxicity [87,88]. The gene discussed is EPO; the disease is Parkinson disease.